Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use

Drug and Alcohol Review

Volumn 29, Issue 3, 2010, Pages 318-330

  Calabria, Bianca ^a   Degenhardt, Louisa ^a   Hall, Wayne ^b   Lynskey, Michael ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis; Drug; Mortality; Review; Risk

Indexed keywords

CANNABIS ADDICTION; CAUSE OF DEATH; EPIDEMIOLOGY; HUMAN; MORTALITY; NEOPLASM; REVIEW; RISK; STATISTICS; SUICIDE; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; CAUSE OF DEATH; EPIDEMIOLOGIC STUDIES; HUMANS; MARIJUANA ABUSE; NEOPLASMS; RISK; SUICIDE;

EID: 77957327996     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00149.x     Document Type: Review

References (40)

1. Hall W, Johnston L, Donnelly N. Epidemiology of cannabis use and its consequences. In: Kalant H, Corrigall W, Hall W, Smart R, eds. The health effects of cannabis. Toronto: Centre for Addiction and Mental Health, 1999:71-125.
2. Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998;352:1611-16.
3. WHO. Cannabis: a health perspective and research agenda. Geneva: World Health Organization, 1997.
4. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;293:2008-12.
5. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthinging the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLOS Med 2007;4:1628-54.
6. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7.
7. Mohler DM, Schulz KF, Altman DG for the CONSORT Group. The CONSORT statement: revisisted recomendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
8. Saha S, Barendregt JJ, Vos T, Whiteford H, McGrath J. Modelling disease frequency measures in schizophrenia epidemiology. Schizophr Res 2008;104:246-54.
9. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant staus and methodology. BMC Med 2004;2:1741.
10. Andreasson S, Allebeck P. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scand J Soc Med 1990;18:9-15.
11. Sidney S, Beck JE, Tekawa IS, Quesenberry CP Jr, Friedman GD. Marijuana use and mortality. Am J Public Health 1997;87:585-90.
12. Chait LDP, Pierri J. Effects of smoked marijuana on human performance: a critical review. In: Murphy LB, Bartke A, eds. Marijuana/cannabinoids: neurobiology and neurophysiology. Boca Raton: CRC Press, 1992:387-423.
13. Hall W, Solowij N, Lemon J. The health and psychological consequences of cannabis use. Canberra: Australian Publishing Service, 1994. Report No.: National Drug Strategy Monograph No. 25.
14. Fergusson DM, Horwood LJ, Boden JM. Is drivingunder the influence of cannabis becoming a greater risk to driver safely than drink driving? Findings from a longitudinal study. Accid Anal Prev 2008;40:1345-50.
15. Robbe HWJ. Influence of Marijuana on driving. Maastricht: Institute for Human Psychopharmacology, University of Limberg, 1994.
16. Smiley A. Marijuana: on road and driving simulator studies. In: Kalant H, Corrigall W, Hall W, Smart R, eds. The health effects of cannabis. Toronto: Addiction Research Foundation, 1999:173-91.
17. Hall W, Degenhardt L, Lynskey M. The health and psychological consequences of cannabis use. Canberra: Australian Publishing Service, 2001. Report No.: in press.
18. Blows S, Ivers RQ, Connor J, Ameratunga S, Woodward M, Norton R. Marijuana use and car crash injury. [see comment]. Addiction 2005;100:605-11.
19. Bedard M, Dubois S, Weaver B. The impact of cannabis on driving. Can J Public Health 2007;98:6-11.
20. Drummer OH, Gerostamoulos J, Batziris H, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 2004;36: 239-48.
21. Laumon B, Gadegbeku B, Martin J-L, Biecheler M-B, Group SAM. Cannabis intoxication and fatal road crashes in France: population based case-control study. [erratum appears in BMJ 2006; 332(7553):1298]. Br Med J 2005; 331:1371.
22. Efird JT, Friedman GD, Sidney S, et al. The risk for malignant primary adult-onset glioma in a large, multiethnic managed-care cohort: cigarette smoking and other lifestyle behaviours. J Neurooncol 2004;68:57-68.
23. Sidney S, Quesenberry CP, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 1997;8:722-8.
24. Hashibe M, Morgenstern H, Cui Y, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006;15:1829-34.
25. Llewellyn CD, Linklater K, Bell J, HJohnson NW, Wanakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004;40: 304-13.
26. Rosenblatt KA, Daling JR, Chen C, Sherman KJ, Schwartz SM. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res 2004;64:4049-54.
27. Sasco AJ, Merrill RM, Dari I, et al. A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 2002;13:609-16.
28. Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008;31:280-6.
29. Chacko JA, Heiner JG, Siu W, Macy M, Terris MK. Association between marijuana use and transitional cell carcinoma. Urology 2006;67:100-4.
30. Zhang ZF, Morgenstern H, Spitz M. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999;8:1071-8.
31. De Leo D, Cerin E, Spathonis K, Burgus S. Lifetime risk of suicide ideation and attempts in an Australian community: prevalence, suicidal process, and help-seeking behaviour. J Affect Disorder 2005;86:215-24.
32. Beautrais AL, Joyce PR, Mulder RT. Cannabis abuse and serious suicide attempts. Addiction 1999;94:1155-64.
33. Kung H-C, Pearson JL, Liu X. Risk factors for male and female suicide decedents ages 15-64 in the United States. Results from the 1993 National Mortality Followback Survey. Soc Psychiatry Psychiatr Epidemiol 2003;38:419-26.
34. Wilcox HC, Anthony JC. The development of suicide ideation and attempts: an epidemiologic study of first graders followed into young adulthood. Drug Alcohol Depend 2004;76(Suppl.):S53-67.
35. Fergusson DM, Horwood LJ, Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002;97:1123-35.
36. Mukamal KJ, Maclure M, Muller JE, Mittleman MA. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 2008;155:465-70.
37. Kandel DB, ed. Stages and pathways of drug involvement: examining the gateway hypothesis. England: Cambridge University Press, 2002.
38. Hall W, Lynskey MT. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev 2005;24:39-48.
39. Degenhardt L, Hall W, Warner-Smith M, Lynskey MT. Illicit drug use. In: Ezzatil M, Lopez LD, Rodgers A, Murray CJL, eds. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organisation, 2004:1109-75.
40. Hashibie M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang Z. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005;35:265-75.